---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-040948"
form_type: "8-K"
ticker: "NKTX"
cik: "0001787400"
company_name: "Nkarta, Inc."
filed_at: "2023-08-10T23:59:59+00:00"
generated_at: "2026-06-11T18:39:58.961049+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Nkarta Q2 net loss $33.3M ($0.68/share); cash $302.2M; NKX101 shows 67% CR/CRi with Flu/Ara-C

## Summary
- Cash and investments $302.2M as of June 30, 2023; cash runway into 2025.
- R&D expense $25.1M; G&A $11.7M; non-cash impairment charge $4.1M on right-of-use assets.
- NKX101: 4/6 CR/CRi (67%) in AML patients after Flu/Ara-C lymphodepletion; no dose-limiting toxicities.
- NKX019 updated data from Phase 1 NHL trial presented at EHA and ICML; expansion cohorts enrolling.
- Alyssa Levin appointed CFO and Chief Business Officer effective July 2023.

## SEC filing metadata
- accession: 0000950170-23-040948
- form_type: 8-K
- ticker: NKTX
- cik: 0001787400
- company_name: Nkarta, Inc.
- filed_at: 2023-08-10T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787400/000095017023040948/0000950170-23-040948-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787400/000095017023040948/nktx-20230810.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-040948
- JSON: https://secwatch.observer/filing/0000950170-23-040948.json
- Plain text: https://secwatch.observer/filing/0000950170-23-040948.txt

## Key facts
- Earnings Releases
  Nkarta, Inc. reported second quarter ended June 30, 2023 results: net income Net loss was $33.3 million, or $0.68 per basic and diluted share, EPS $0.68 per basic and diluted share.
  - Period: second quarter ended June 30, 2023
  - Net income: Net loss was $33.3 million, or $0.68 per basic and diluted share
  - EPS: $0.68 per basic and diluted share
  - Result: reported results
  source text: Nkarta Reports Second Quarter 2023 Financial Results and Corporate Highlights
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787400/000095017023040948/0000950170-23-040948-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.